Trial · NCT03757078
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Severity of pain (VAS: Visual Analogue Scale) | Up to 14 days | Pain was measured on a Visual Analogue Scale (VAS) from 0 (No Pain) to 10 (Maximal Pain). |
| Primary | Severity of bleeding (according to 4-point Likert scale) | Up to 14 days | 4-point Likert scale consisting of: 1 (None), 2 (Minimal), 3 (Moderate) and 4 (Significant). |
| Primary | Severity of pruritus (according to 4-point Likert scale) | Up to 14 days | |
| Primary | Severity of swelling (according to 4-point Likert scale) | Up to 14 days | |
| Primary | Severity (amount) of discharge (according to 4-point Likert scale) | Up to 14 days | |
| Primary | Severity of sense of discomfort (according to 4-point Likert scale) | Up to 14 days | |
| Primary | Overall patient satisfaction with treatment (according to 5-point Likert scale) | Up to 14 days | Likert scale: 1 (Very satisfied), 2 (Satisfied), 3 (Neither satisfied nor dissatisfied), 4 (Dissatisfied) and 5 (Very dissatisfied). |
| Primary | Time to onset of analgesic effect after the first use of the drug | Up to 14 days | |
| Primary | Duration of analgesic effect after the first use of the drug | Up to 14 days | |
| Primary | Patient's adherence to recommendations of the Investigator by PRO | Up to 14 days | PRO: Patient Reported Outcome |
| Primary | Information obtained in the course of questioning about the consumer properties of the study product by PRO | Up to 14 days | |
| Primary | Severity of hemorrhoids symptoms according to the Sodergren score | Up to 14 days | Standardized answer options are given (4 and 5 Likert boxes) and each question gets a score from 0 to 4. |
| Primary | Size of the largest hemorrhoid node measured during a routine examination | Up to 14 days | |
| Primary | Severity of swelling when assessed as part of routine examination (according to 4-point Likert scale) | Up to 14 days | |
| Primary | Severity of bleeding when assessed as part of routine examination (according to 4-point Likert scale) | Up to 14 days | |
| Primary | Amount of ReliefPro used based on information provided by the patient to the Investigator | Up to 14 days | |
| Primary | Overall satisfaction of Investigator with treatment with Relief Pro according Likert scale from 1 to 5 points as measured on Visits 2 and 3 | Up to 14 days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03757078/registered